AstraZeneca Says UK Tax Rate Discourages Pharma Investment
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
64,809$
0,26%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca CEO say UK business climate deters investment
...By Natalie Grover and Maggie Fick
LONDON (Reuters) -Britains......…
UPDATE 2-AstraZeneca CEO say UK business climate deters investment
...
LONDON, Feb 9 (Reuters) - Britains business climate is
deterring pharma......…
AstraZeneca trades higher as Q4 revenue sans COVID products grows; sees sales uptick in FY23
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Swung to 4Q Profit, But Covid-19 Shot Decline Hit Revenue -- Update
AstraZeneca Swung to 4Q Profit, But Covid-19 Shot Decline Hit Revenue -- Update...…
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of…
LONDON BRIEFING: AstraZeneca swings to profit; Unilever volumes fall
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
TOP NEWS: AstraZeneca swings to profit as Alexion adds to 2022 revenue
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Nach Gewinnsprung für Astrazeneca: Weniger Covid-Verkäufe dürften 2023 bremsen
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern AstraZeneca hat trotz eines schwierigen Schlussquartals im vergangenen Jahr deutlich mehr verdient. Dabei profitierte das…
US Co. Results: AstraZeneca 4Q Revenue Plunges 7%, Slightly Misses Consensus
Multinational pharmaceutical giant AstraZeneca (AZN.US)'s adjusted earnings per share (EPS) in the fourth quarter were US$1.38, higher than the expected…
Astrazeneca wieder mit Gewinn - Corona-Impfstoff belastet Umsatz
Von Cecilia Butini LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat im vierten Quartal wegen rückläufiger Verkäufe seines Covid-19-Impfstoffs Vaxzevria weniger…
Astrazeneca Swings To Profit In Q4, But Revenue Falls
LONDON (dpa-AFX) - Astrazeneca Plc (AZN.L), a British-Swedish drug major, on Thursday reported a turnaround to profit for the fourth-quarter.…
AstraZeneca PLC 4Q EPS 58c
AstraZeneca PLC 4Q EPS 58c...…
BUSINESS LIVE: Unilever lifted by price hikes; AZ sales miss forecasts
Among the companies with reports and trading updates today are Unilever, British American Tobacco, AstraZeneca, Bellway, Compass Group and Redrow....…
AstraZeneca Reports Profit Beat, Sees Growth Amid New Drug ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Q4 revenue just shy of analyst estimates
...LONDON (Reuters) - AstraZeneca on Thursday posted fourth-quarter......…
UPDATE 1-AstraZeneca Q4 revenue just shy of analyst estimates
...(Adds 2023 forecast, paragraph 4)
LONDON, Feb 9 (Reuters......…
AstraZeneca reports mixed Q4 earnings; issues FY23 soft guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Expected to Swing to 4Q Profit -- Earnings Preview
AstraZeneca Expected to Swing to 4Q Profit -- Earnings Preview...…
AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure
LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L) announced Forxiga has been approved in the European Union to extend the indication for…
Astrazeneca-Arnzei Forxiga in der EU bei Herzinsuffizienz zugelassen
Von Kyle Morris LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca kann einen Zulassungserfolg für das Medikament Forxiga verbuchen. Wie das Unternehmen…
AstraZeneca Says Forxiga Approved in EU for Heart Failure
AstraZeneca Says Forxiga Approved in EU for Heart Failure...…
Global Therapeutic Monoclonal Antibodies Market Research Report 2022 Featuring Eli Lily and Co, GSK, Roche, Astra Zeneca, Bayer, Amgen, Johnson & Johnson, Pfizer, Novartis, Merck & Co.
DUBLIN, Feb. 6, 2023 /PRNewswire/ -- The "Global Therapeutic Monoclonal Antibodies Market - Analysis By Source, Target, Indication, Route of…
BioStock: LS cluster in Gothenburg: a successful experiment
Life Science is an important sector for western Swedens business community, and the life science cluster in Gothenburg is growing…
Global COPD and Asthma Devices Market 2022 - 2027: Players Include Adherium, Aristopharma, AstraZeneca, Baxter International and Boehringer Ingelheim International
DUBLIN, Feb. 3, 2023 /PRNewswire/ -- The "COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and…
Week ahead: AstraZeneca, BP, BAT, Unilever bring big dividends ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $63.15, moving -0.65% from the previous trading session....…
AstraZeneca: Will pharma giant beat revenue expectations?
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: Feb 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Total Voting Rights
1 February 2023 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZeneca begins late-stage trial of datopotamab, Keytruda combo for NSC lung cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Capitainer announces collaboration with AstraZeneca
The Swedish medtech company Capitainer AB today announces a research collaboration with AstraZeneca. AstraZeneca R&D Gothenburg will use a novel…
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $65.53, moving -0.7% from the previous trading session....…
ADRs End Higher; AstraZeneca, Diageo Trade Actively
ADRs End Higher; AstraZeneca, Diageo Trade Actively...…
AstraZeneca’s preventive COVID therapy no longer effective against current variants
AstraZeneca AZNUK:AZN said Thursday that the Food and Drug Administration is no longer allowing healthcare providers to prescribe Evusheld, a…
Form 6-K ASTRAZENECA PLC For: Jan 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Update on Evusheld US EUA
26 January 2023 18:15 GMT
Update on US Food and Drug Administration
Emergency Use Authorisation of Evusheld
The US Food and Drug Administration (FDA)…
AstraZeneca COVID-19 antibody therapy no longer authorized in U.S.
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Total Voting Rights
1 August 2022 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
Astrazeneca (AZN) Dips More Than Broader Markets: What You Should Know
Astrazeneca (AZN) closed at $66.28 in the latest trading session, marking a -1.97% move from the prior day....…
ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively
ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively...…
ADRs End Higher; AstraZeneca, Barclays Trade Actively
ADRs End Higher; AstraZeneca, Barclays Trade Actively...…
Top Analyst Reports for AstraZeneca, NextEra Energy & Boeing Company
Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), NextEra Energy, Inc. (NEE) and…
Tempted by the AstraZeneca share price? Here’s why it could explode in 2023
The AstraZeneca share price has more than doubled over five years. Our writer outlines why the FTSE 100 healthcare stock…
AstraZeneca starts tender offer to acquire CinCor
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Commencs Tender Offer To Buy CinCor Pharma
LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) Monday said it is commencing a tender offer to buy…
AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca slips as Stifel warns about generic competition, lowered COVID product sales
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Non-Viral / Intracellular Drug Delivery Systems Global Market Report 2022: Featuring 20Med Therapeutics, AstraZeneca, BioNTech, Deloitte & More
DUBLIN, Jan. 19, 2023 /PRNewswire/ -- The "Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of…